Sequential one-pot synthesis of bis(indolyl)glyoxylamides: Evaluation of antibacterial and anticancer activities.
Sequential one-pot synthesis of bis(indolyl)glyoxylamides: Evaluation of antibacterial and anticancer activities.
复制标题
双(吲哚基)乙醛酰胺的连续一锅合成:抗菌和抗癌活性评价。
DOI:
10.1016/j.bmcl.2016.04.080
复制
发表时间:
2016
影响因子:
2.7
通讯作者:
Kumar,Dalip
中科院分区:
文献类型:
--
作者:
Tantak,MukundP;Gupta,Vishakha;Nikhil,Kumar;Arun,V;Singh,RajnishPrakash;Jha,PrabhatNath;Shah,Kavita;Kumar,Dalip
A series of bis(indolyl)glyoxylamides10a–nhas been designed and synthesized. In situ generated indole-3-glyoxalylchloride from the reaction of readily available indole9with oxalyl chloride was treated with tryptamine to produce bis(indolyl)glyoxylamides10a–nin 82–93% yields. All the synthesized bis(indolyl)glyoxylamides were well characterized and tested for their antibacterial activity against Gram-positive and Gram-negative bacterial strains. Compounds10d,10gand10iwere found to display potent antibacterial activity against Gram-negative strain. Further, the cytotoxicity of bis(indolyl)glyoxylamides10a–nwere evaluated against a panel of human cancer cell lines. Of the screened analogues, compound10f(IC50= 22.34 μM; HeLa, 24.05 μM; PC-3, 21.13 μM; MDA-MB-231 and 29.94 μM; BxPC-3) was identified as the most potent analogue of the series. Exposure of PC-3 cells to either10aor10fresulted in increased levels of cleaved PARP1, indicating that bis(indolyl)glyoxylamides induce apoptosis in PC-3 cells. Most importantly, compounds10d,10gand10iwere completely ineffective in mammalian cells, suggesting that they target bacterial-specific targets and thus will not display any toxicity in host cells.